Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 5/20 | 0.62 |
| ▸ | CA12 | O43570 | 4/20 | 0.62 |
| ▸ | CA1 | P00915 | 4/20 | 0.62 |
| ▸ | CA7 | P43166 | 4/20 | 0.62 |
| ▸ | CA9 | Q16790 | 4/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | CA4 | P22748 | 1/20 | 0.62 |
| ▸ | CA6 | P23280 | 1/20 | 0.62 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | DBH | P09172 | 1/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | XDH | P47989 | 1/20 | 0.54 |
| ▸ | PARP1 | P09874 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Protocatechuamide SCHEMBL28613093 | 0.98 | LCK (0.63) | LCKCA2CA12CA1CA7 | |
| Protocatechuamide SCHEMBL3330438 | 0.84 | CA12 (0.50) | LCKCA2CA12CA1CA7 | |
| SCHEMBL28842093 | 0.81 | CA12 (0.58) | LCKCA2CA12CA1CA7 | |
| SCHEMBL11337357 | 0.81 | LCK (0.55) | LCKCA2CA12CA1CA7 | |
| SCHEMBL1805788 | 0.81 | LCK (0.55) | LCKCA2CA12CA1CA7 | |
| SCHEMBL926368 | 0.81 | LCK (0.55) | LCKCA2CA12CA1CA7 | |
| SCHEMBL3015286 | 0.81 | LCK (0.55) | LCKCA2CA12CA1CA9 | |
| SCHEMBL5595306 | 0.81 | LCK (0.55) | LCKCA2CA12CA1CA7 | |
| SCHEMBL1489540 | 0.81 | CA12 (0.58) | LCKCA2CA12CA1CA7 | |
| SCHEMBL31746203 | 0.81 | CA12 (0.57) | LCKCA2CA12CA1CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059965-A | Preparation method of Icotinib hydrochloride | 重庆圣华曦药业股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-119161159-A | High-strength black sand ceramic for furniture and preparation process thereof | 馆陶县陶山黑陶科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-118459943-B | Preparation method of hydrophobic polyester tire | 山东鸿泰新材料有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118459943-A | Preparation method of hydrophobic polyester tire | 山东鸿泰新材料有限公司 | 2024-08-09 | — | — | CN | claimed |
| US-20230255906-A1 | Targeting Serpin B9 in Cancer | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2023-08-17 | — | — | US | claimed |
| CN-115427142-A | Perovskite solar cell provided with adsorbing material for adsorbing toxic substances | 洛桑联邦理工学院(EPFL) | 2022-12-02 | — | — | CN | claimed |
| US-20200205541-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | L'OREAL (FR) | 2020-07-02 | — | — | US | claimed |
| EP-1511710-B1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER S DISEASE, TYPE 2 DIABETES, AND PARKINSON S DISEASE | PROTEOTECH INC (US) | 2013-11-20 | — | — | EP | claimed |
| US-20130298933-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | L'OREAL (FR) | 2013-11-14 | — | — | US | claimed |
| CN-102863395-A | Novel method for synthesizing Erlotinib | BEIJING LIUSHENGHE MEDICAL TECHNOLOGY CO LTD | 2013-01-09 | — | — | CN | claimed |
| US-6509352-B1 | Selectively act on cannabinoid receptors, particularly on peripheral type cannabinoid receptors, and have fewer side effects on the central nervous system, having great immunosuppressive action, anti-inflammatory action or | JAPAN TOBACCO INC. (JP) | 2003-01-21 | — | — | US | claimed |
| EP-0900781-B1 | Phenolic acid amides of hydroxy substituted benzylamines | HAARMANN & REIMER GMBH (DE) | 2002-03-20 | — | — | EP | claimed |
| EP-1142877-A1 | 2-OXOQUINOLINE COMPOUNDS AND MEDICINAL USES THEREOF | JAPAN TOBACCO INC. (JP) | 2001-10-10 | — | — | EP | claimed |
| EP-1068187-A1 | PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION | ABBOTT LABORATORIES (US) | 2001-01-17 | — | — | EP | claimed |
| WO-1999051580-A1 | PYRAZOLE INHIBITORS OF CYTOKINE PRODUCTION | ABBOTT LABORATORIES (US) | 1999-10-14 | — | — | WO | claimed |
| US-5843618-A | Hydrogen bond donating/accepting thermal solvents for image separation systems | EASTMAN KODAK COMPANY (US) | 1998-12-01 | — | — | US | claimed |
| EP-0692733-B1 | Direct thermal recording process | AGFA GEVAERT NV (BE) | 1998-02-04 | — | — | EP | claimed |
| US-5582953-A | IMAGING LAYER CONTAINING SILVER SALTS AND ORGANIC DIHYDROXYL-CONTAINING REDUCING AGENT THEREFOR | AGFA-GEVAERT N.V. (BE) | 1996-12-10 | — | — | US | claimed |
| EP-0692733-A2 | Direct thermal recording process | AGFA-GEVAERT N.V. (BE) | 1996-01-17 | — | — | EP | claimed |
| EP-0142241-B1 | DIHYDROXYBENZAMIDE DERIVATIVES HAVING ANTI-INFLAMMATORY ACTIVITY | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1987-12-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200205541-A1 | METHOD FOR STRAIGHTENING KERATINOUS FIBERS USING HEATING MEANS AND AN AROMATIC COMPOUND | KRT18, TUBB4A, TUBB4B | LCK 539/4885CA2 2393/4885CA12 1543/4885 |
| US-20230255906-A1 | Targeting Serpin B9 in Cancer | SERPINB10, SERPINB8, SERPINE1 | LCK 4817/4885CA2 4819/4885CA12 4255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.